Literature DB >> 3155877

The immune derangement in Hodgkin's disease.

S Romagnani, P L Ferrini, M Ricci.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 3155877

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  6 in total

1.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Lectin activity as a marker for Hodgkin disease cells.

Authors:  E Paietta; R J Stockert; A G Morell; V Diehl; P H Wiernik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.

Authors:  S Viviani; E Camerini; V Bonfante; A Santoro; M Balzarotti; M Fornier; L Devizzi; P Verderio; P Valagussa; G Bonadonna
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

4.  Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.

Authors:  G Mantovani; A Macciò; G Astara; L Contini; S Esu; S Littera; V Arangino; P Lai; E Proto; G Pusceddu
Journal:  Cell Biophys       Date:  1993 Jan-Jun

5.  Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

Authors:  R N Damle; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

6.  Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

Authors:  N Rajaram; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.